Patient | Age | Fusion levels | DBX® in situ (month) | DBX® residuals (+/++/+++/++++) | New bone formation (+/++/+++/+++++) |
---|---|---|---|---|---|
1 | 31 | T10-T12 | 7 | + | +++ |
2 | 52 | T11-L1 | 18 | - | ++++ |
3 | 50 | T11-L1 | 8 | + | +++ |
4 | 39 | T12-L2 | 9 | ++ | ++ |
5 | 39 | T12-L2 | 8 | ++ | ++ |
6 | 64 | T5-T9 | 8 | +++ | + |
7 | 30 | T12-L2 | 17 | - | ++++ |
8 | 46 | T2-T5 | 6 | ++ | ++ |
9 | 48 | T11-L1 | 9 | ++ | ++ |